|
RESPIRATORY NEWS
75% of asthma patients without management plan. May 09
Three out of four asthma patients in Ireland do not have an asthma management
plan, an essential element in controlling the condition, a new survey reveals. read more...
COPD exacerbations linked to depression and anxiety. Oct 08
COPD patients with symptoms of depression were at a 51% to 56% increased risk
of exacerbation and a 72% increased risk of hospitalization, reported a study in
the 1. Nov 08 issue of the American Journal of Respiratory and Critical care Medicine.
read more...
Asthma hospitalizations due to poor adherence. Dec 04
The majority of hospitalizations for asthma may be the result of people not
taking their inhaled steroid medications, according to research featured in the
Dec 2004 Journal of Allergy & Clinical Immunology (JACI). read more...
|
Smartinhaler Tracker for Symbicort/Vannair Validated. Dec 09
New product Smartinhaler Tracker for Symbicort/Vannair passes independent in-vitro validation and released to manufacture for use in clinical trials. read more...
Nexus6 receives FDA clearance to market. Nov 09
Nexus6 announced it has received
510(k) clearance to market form the U.S. Food and Drug Administration for its new
SmartTrack electronic medication monitor and Respiratory Analyzer software. read more...
Nexus6 signs OEM co-regulatory agreement. Oct 09
Nexus6 signs a OEM co-regulatory agreement with a leading global healthcare company
to progress remote patient compliance monitoring technology through the regulatory
approval process.
SmartTurbo released. Jul 09
SmartTurbo
Nexus6 Signs OEM co-development agreement. Jun 09
Nexus6 signs another OEM co-development agreement with a leading global healthcare
company to add Nexus6’s remote patient compliance monitoring technology to their
device platform.
SmartTrack & SmartDisk released. Jun 09
SmartTrack SmartDisk
Nexus6 at ATS and RDD. May 09
Nexus6 demonstrated the new SmartTrack and SmartDisk at ATS (San Diego) and RDD
(Lisbon) to existing and new customers.
MicroDose - Nexus6. Jan 09
MicroDose Therapeutx (MDT) and Nexus6 Ltd announce collaboration to evaluate application
of remote patient compliance monitoring technology with MDT's electronic dry powder
inhaler. read more...
RRA v4.8 released. Oct 08
Respiratory Research Analyser v4.8 released. This version simplifies entry of and
updates to participant baseline data. Also contains additional report formats requested
for specific SPSS tasks.
TGA approval received. Aug 08
Therapeutic Goods Administration (TGA) approval received for Smartinhaler Backpack.
SmartinhalerLiveTM goes live.
Jul 08
New product SmartinhalerLiveTM goes Live at first customer site.
DoseCount shipped. Jun 08
New product Smartinhaler DoseCount released and shipped to its 1st clinical
trial.
Smartinhaler Tunes at ATS. May 08
Trial results for Smartinhaler Tunes presented at American Thoracic Society Meeting,
Toronto.
Smartinhaler demo at RDD. May 08
Nexus6 demostrates Smartinhalers at Respiratory Drug Delivery (RDD), Scottsdale
Arizona.
|
ADHERENCE RESEARCH
Assessing adherence and factors associated with adherence in young children
with asthma
Conclusion: Adherence with preventive medication, even within the
context of a research study, was generally low and highly variable. Subjective measures
of adherence were found to overestimate adherence in young asthmatics.
read more...
An inhaler with ring tones improves compliance with inhaled steroids in childhood
asthma.
Conclusion: The use of an inhaler with ring tones as a reminder alarm
was associated with significantly greater adherence with inhaled steroids during
the study.
read more...
An audiovisual reminder function improves adherence with inhaled corticosteroid
therapy in asthma.
Conclusion: An audiovisual reminder function can significantly improve
adherence with ICS therapy in adult asthma.
Clinical implications: An audiovisual function has potential to improve adherence
with medication regimes across a wide spectrum of diseases, in both research and
clinical practice.
read more...
Should patients with persistent severe asthma be monitored for medication adherence?
Conclusion: By correctly assessing nonadherence as the cause of treatment
failure in patients with not only severe asthma but mild and moderate disease as
well, practicing physicians may improve the quality of care provided. Ann Allergy
Asthma.
read more...
|